Castellum, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTM research report →
Range $3 – $3
Price Chart
About the company
Castellum, Inc. is a firm specializing in providing advanced services across critical domains such as cybersecurity, information technology, electronic warfare, and both information warfare and operations. Its comprehensive suite of capabilities encompasses intelligence analysis, full-lifecycle software development and engineering, strategic program management, mission planning, robust information assurance, and specialized support for cybersecurity policy, alongside sophisticated data analytics.
- CEO
- Glen R. Ives
- IPO
- 2022
- Employees
- 244
- HQ
- Vienna, VA, US
Get TickerSpark's AI analysis on CTM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $35.27M
- P/E
- -12.64
- PEG
- 0.83
- P/S
- 0.72
- P/B
- 1.10
- EV/EBITDA
- -15.16
- Div Yield
- 0.00%
- Gross Margin
- 34.91%
- Op Margin
- -6.76%
- Net Margin
- -5.69%
- ROE
- -8.75%
- ROIC
- -10.07%
Latest fiscal year · YoY change
- Revenue
- $52.87M+18.1%
- Gross Profit
- $19.37M+6.0%
- Op Income
- $-2,814,562
- Net Income
- $-2,398,292+76.0%
- EPS
- $-0.03+85.0%
- OCF Growth
- -273.9%
- FCF Growth
- -288.0%
- 52W High
- $1.24
- 52W Low
- $0.34
- 50D MA
- $0.55
- 200D MA
- $0.68
- Beta
- -4.29
- RSI (14)
- 32
- Avg Volume
- 549.67K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Castellum posted modest Q3 growth, maintained positive cash generation and a debt-free balance sheet, and reiterated that record 2026 revenue is expected even as near-term margins are pressured by investment spending and contract mix.· November 6, 2026
- Nine-month revenue rose 6% to $42.9 million, and management said full-year 2026 revenue should be a record.
- Q3 revenue was $14.7 million, gross profit was $5.3 million, gross margin was 36.1%, and adjusted EBITDA was positive at about $600,000.
- Backlog ended at $254.5 million, while qualified pipeline hit a record $1.66 billion, boosted by business-development spending and larger opportunities.
- Management said margin pressure came from higher subcontractor mix and deliberate investment in business development and M&A.
- The company ended the quarter with $15.7 million in cash, $8.8 million in net accounts receivable, no debt, and said reverse split is not on the table right now.
Third-quarter revenue was $14.7 million, up slightly from $14.6 million a year ago and up from $13.9 million last quarter. Gross profit was $5.3 million versus $5.5 million last year, and gross margin was 36.1% compared with 37.6% a year ago; management said margin improved sequentially from about 34% in Q2. Adjusted EBITDA was positive at approximately $600,000 versus $1.1 million last year, and the company reported a net loss of about $500,000 versus net income of $400,000 a year ago. For the first nine months, revenue rose 6% to $42.9 million from $40.3 million, gross profit was $15.1 million, gross margin was 35.2% versus 37.5%, adjusted EBITDA was about $1 million versus $1.8 million, and net loss was $1.8 million versus $1.1 million. Operating cash flow for the nine months was $1.1 million, a $2.4 million improvement from a $1.3 million use last year. The company ended with $15.7 million in cash, $8.8 million in net accounts receivable, $24.5 million combined, no outstanding debt, and about $36.3 million of stockholders’ equity. Backlog was $254.5 million, including $18.2 million funded and $236.3 million unfunded, and management expects to recognize about 25% over the next 12 months and about 51% over the next 24 months. Guidance/commentary: management continues to expect record full-year 2026 revenue and said benefits from business-development and M&A investments should begin showing over the next 6 to 12 months.
Glen Ives framed the quarter as part of a longer-term build toward scale, not a one-quarter story. He emphasized that organic growth is important but not enough on its own, and said M&A is central to the company’s strategy to accelerate growth and improve earnings potential. His tone was confident and urgent: he repeatedly pointed to the strong balance sheet, long-duration contracts, and a desire to move quickly but deliberately on the right acquisition.
David Bell emphasized that the financials reflect planned investment spending rather than an operational stumble. He cited Q3 revenue of $14.7 million, gross margin of 36.1%, adjusted EBITDA of about $600,000, and a nine-month operating cash flow swing to +$1.1 million from -$1.3 million last year. He also highlighted liquidity of $24.5 million combined cash and net receivables, no debt, and said the company is taking a measured approach to M&A and business development while preserving financial flexibility.
Analysts and shareholders focused on whether the larger pipeline and backlog imply faster conversion, and management said the pipeline is strong but timing remains uneven in government contracting; Drew Merriman said current-contract growth accounts for most open positions and described the top programs and their ramp profiles. A major topic was capital allocation, especially buybacks versus M&A: Glen said a buyback may be discussed, but near term the company intends to use cash for the right acquisition because organic growth alone and buybacks are not enough to scale. Another concern was a reverse split; David said it is not on the table right now and management prefers to grow the company and let the market recognize execution over time.
The bull case is that Castellum has multiple long-duration government programs, a record $1.66 billion pipeline, and expects record full-year revenue in 2026. The company is debt-free, has positive operating cash flow, and management believes its business-development and M&A investments should start producing visible benefits over the next 6 to 12 months.
The main risks raised on the call are margin pressure from contract mix, uneven quarter-to-quarter revenue timing, and the fact that near-term EBITDA is being weighed down by investment spending. Investors also pressed management on the weak stock price and the possibility of a reverse split, underscoring skepticism that organic growth and pipeline visibility alone will translate into shareholder returns without successful M&A execution.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 87.9%
- Shares Outstanding
- 95.02M
- Float Shares
- 83.51M
of shares held by institutions
35 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 3.47M | ▲ 2.20M |
| Vanguard Capital Management LLC | 3.05M | ▼ 45.28K |
| Meridian Wealth Management, LLC | 907.10K | ▲ 43.90K |
| Geode Capital Management, LLC | 804.50K | ▼ 11.54K |
| Captrust Financial Advisors | 626.10K | 0 |
| Vanguard Fiduciary Trust Co | 492.72K | 0 |
| State Street Corp | 303.90K | 0 |
| Blackrock, Inc. | 265.49K | 0 |
| Ubs Group AG | 237.06K | ▲ 28.10K |
| Savvy Advisors, Inc. | 216.30K | ▼ 4.00K |
| Northern Trust Corp | 171.42K | ▼ 10.48K |
| Virtu Financial LLC | 168.40K | ▲ 168.40K |
Held by 23 ETFs
Biggest fund positions in CTM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 16, 26 | Bell David T | buy | 51,886 |
| Nov 10, 26 | Merriman Andrew | buy | 50,000 |
| Oct 1, 26 | MARTIN TAMMY L | buy | 1,396 |
| Oct 1, 26 | Bell David T | buy | 1,396 |
| Oct 1, 26 | Merriman Andrew | buy | 1,396 |
| Oct 1, 26 | Ives Glen R | buy | 1,700 |
| Sep 9, 26 | Merriman Andrew | buy | 10,000 |
| Sep 9, 26 | Merriman Andrew | buy | 40,000 |
| Jul 1, 26 | Merriman Andrew | buy | 1,202 |
| Jul 1, 26 | Bell David T | buy | 1,202 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CTM coverage
Recent articles, reports, and earnings notes.
No research on CTM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTM report →Castellum Announces $6.0 Million Share Repurchase Program
globenewswire.com · Nov 9
Castellum, Inc. (CTM) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 6
Castellum Schedules Third Quarter 2026 Earnings Release and Conference Call
globenewswire.com · Oct 28
Castellum AB (publ) (CWQXY) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 22
Castellum Q2 Earnings Call Highlights
marketbeat.com · Aug 9
Castellum Schedules Second Quarter 2026 Earnings Release and Conference Call
globenewswire.com · Jul 31
Castellum Schedules Second Quarter 2026 Earnings Release and Conference Call
globenewswire.com · Jul 31
Castellum AB (publ) (CWQXY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.